| HPT | histamine provocation test; human placental thyrotropin; hyperparathyroidism; hypothalamo-pituitary-... |
|---|---|
| LAP | laparoscopy; laparotomy; left arterial pressure; left atrial pressure; leucine aminopeptidase; leuke... |
| NPA | National Pharmaceutical Association; National Pituitary Agency; near point accommodation; Nurse Prac... |
| PA | panic attack; pantothenic acid; paralysis agitans; paranoia; passive aggressive; pathology; patient'... |
| PACAP | pituitary adenylate cyclase activating polypeptide |
| local hormone | A metabolic product secreted by one set of cells that affects the function of nearby cells; an autacoid; e.g., prostaglandins and neurotransmitters. (05 Mar 2000) |
|---|---|
| luteinising hormone | <endocrinology> A glycoprotein hormone (26 kD) and gonadotrophin. Made up of an _ chain (96 amino acids) identical to other gonadotrophins and a hormone specific _ chain. Acts with follicle-stimulating hormone to stimulate sex hormone release. (18 Nov 1997) |
| luteinising hormone releasing factor | A decapeptide releasing hormone (1182D) that stimulates release of luteinising hormone. (18 Nov 1997) |
| luteinizing hormone | <protein> Synonym for luteinising hormone. (18 Nov 1997) |
| luteinizing hormone-releasing factor | Former name for luteinizing hormone-releasing hormone. (05 Mar 2000) |
| luteotropic hormone | An anterior pituitary hormone whose action maintains the function of the corpus luteum. Synonym: luteotropic hormone. (05 Mar 2000) |
| adrenergic receptors | Reactive components of effector tissues, most of which are innervated by adrenergic postganglionic fibres of the sympathetic nervous system. Such receptor's can be activated by norepinephrine and/or epinephrine and by various adrenergic drugs; receptor activation results in a change in effector tissue function, such as contraction of arteriolar muscles or relaxation of bronchial muscles; adrenergic receptor's are divided into alpha-receptor's and beta-receptor's, on the basis of their response to various adrenergic activating and blocking agents. Synonym: adrenoceptor, adrenoreceptors. (05 Mar 2000) |
| alpha-adrenergic receptors | Adrenergic receptor's in effector tissues capable of selective activation and blockade by drugs; conceptually derived from the ability of certain agents, such as phenoxybenzamine, to block only some adrenergic receptor's and of other agents, such as methoxamine, to activate only the same adrenergic receptor's. Such receptor's are designated as alpha-receptors. Their activation results in physiological responses such as increased peripheral vascular resistance, mydriasis, and contraction of pilomotor muscles. (05 Mar 2000) |
| ANP clearance receptors | Cell surface proteins that bind atrial natriuretic peptide and ANP fragments without initiating biological action. (05 Mar 2000) |
| ANP receptors | Cell surface receptors for atrial natriuretic peptide that have a single transmembrane spanning element; these have integral kinase and guanylate cyclase domains. (05 Mar 2000) |
| B-cell antigen receptors | In the primary immune response immunoglobulin D and monomeric immunoglobulin M are the B-cell antigen receptors. On memory B-cells, other immunoglobulin molecules can serve as antigen receptors. (05 Mar 2000) |
| beta-adrenergic receptors | Adrenergic receptor's in effector tissues capable of selective activation and blockade by drugs; conceptually derived from the ability of certain agents, such as propranolol, to block only some adrenergic receptor's and of other agents, such as isoproterenol, to activate only the same adrenergic receptor's. Such receptor's are designated as beta-receptors. Their activation results in physiological responses such as increases in cardiac rate and force of contraction (b1), and relaxation of bronchial and vascular smooth muscle (b2). (05 Mar 2000) |
| mannose-6-phosphate receptors | Receptors in Golgi apparatus to which newly synthesised proteins that are destined to enter lysosomes bind. (05 Mar 2000) |
| receptors, adrenergic | Cell-surface proteins that bind epinephrine and/or norepinephrine with high affinity and trigger intracellular changes. The two major classes of adrenergic receptors, alpha and beta, were originally discriminated based on their cellular actions but now are distinguished by their relative affinity for characteristic synthetic ligands. Adrenergic receptors may also be classified according to the subtypes of g-proteins with which they bind; this scheme does not respect the alpha-beta distinction. (12 Dec 1998) |
| receptors, adrenergic, alpha | One of the two major pharmacological subdivisions of adrenergic receptors. The alpha-beta distinction was originally based on cellular effects of receptor activation but now relies on the relative affinities for certain synthetic ligands. Alpha-adrenergic receptors are further subdivided into several subclasses based on studies of endogenous and cloned receptors. (12 Dec 1998) |